MRNA – Stock Wire News

COVID-19 Vaccine: Moderna Launches Phase 3 Trial

By stock_wire_news, July 27, 2020

We may be nearing a vaccine. Just this morning, Moderna Inc. (MRNA) announced another $472 million commitment from the U.S. government to develop a vaccine. According to SVB Leerink analysts, that commitment will be used to fund a Phase 3 trial for Moderna’s vaccine, which is “set to begin immediately,” as quoted by MarketWatch. In … Continue reading COVID-19 Vaccine: Moderna Launches Phase 3 Trial

Moderna (MRNA) Advances to Next Stage of Vaccine Testing

By stockwirenews, April 28, 2020

We may be nearing a coronavirus vaccine. Just yesterday, Moderna (MRNA) announced it submitted an Investigational New Drug (IND) application to the US FDA for its mRNA candidate to “evaluate mRNA-1273 in Phase 2 and late-stage studies if supported by safety data from the Phase 1 study led by the National Institute of Allergy and … Continue reading Moderna (MRNA) Advances to Next Stage of Vaccine Testing

Confidential Stock Report By